NHS England has introduced new or amended indicators into four clinical areas of QOF for 2020/21 – asthma, COPD, heart failure and diabetes. The new/amended indicator wording and associated points and payment thresholds are detailed below.
| 2019/20 indicator wording | Agreed new wording in 2020/21 | Points | Payment thresholds |
| AST001 The contractor establishes and maintains a register of patients with asthma, excluding patients with asthma who have been prescribed no asthma-related drugs in the preceding 12 months | AST005 The contractor establishes and maintains a register of patients with asthma aged 6 years of over, excluding patients with asthma who have been prescribed no asthma related drugs in the preceding 12 months. (Based on NM165). | 4 | N/A |
| AST002 The percentage of patients aged 8 or over with asthma (diagnosed on or after 1 April 2006), on the register, with measures of variability or reversibility recorded between 3 months before or any time after diagnosis (NM101) | AST006 The percentage of patients with asthma on the register from 1 April 2020 with either: 1) a record of spirometry and one other objective test (FeNO or reversibility or variability) between 3 months before or 6 months after diagnosis; or 2) if newly registered in the preceding 12 months with a diagnosis of asthma recorded on or after 1 April 2020 but no record of objective tests being performed at the date of registration, with a record of spirometry and one other objective test (FeNO or reversibility or variability) recorded within 6 months of registration. (Based on NM166) |
15 | 45-80% |
| AST003 The percentage of patients with asthma, on the register, who have had an asthma review in the preceding 12 months that includes an assessment of asthma control using the three RCP questions (NM23) | AST007 The percentage of patients with asthma on the register, who have had an asthma review in the preceding 12 months that includes an assessment of asthma control using a validated asthma control questionnaire, a recording of the number of exacerbations, an assessment of inhaler technique and a written personalised action plan. (Based on NM167) | 20 | 45-70%w |
| AST004 The percentage of patients with asthma aged 14 or over and who have not attained the age of 20, on the register, in whom there is a record of smoking status in the preceding 12 months (NM102) | AST008 The percentage of patients with asthma on the register aged 19 or under, in whom there is a record of either personal smoking status or exposure to second-hand smoke in the preceding 12 months. (Based on NM168) | 6 | 45-80% |
| 2019/20 indicator wording | Agreed new wording in 2020/21 | Points | Payment thresholds |
| COPD001 The contractor establishes and maintains a register of patients with COPD COPD002 The percentage of patients with COPD (diagnosed on or after 1 April 2011 in whom the diagnosis has been confirmed by post bronchodilator spirometry between 3 months before and 12 months after entering on to the register (NM103) |
COPD009 The contractor establishes and maintains a register of: 1) Patients with a clinical diagnosis of COPD on or after 1 April 2020 and 2) Patients with a clinical diagnosis of COPD on or after 1 April 2020 whose diagnosis has been confirmed by a quality assured post bronchodilator spirometry FEV1/FVC ratio below 0.7 between 3 months before or 6 months after diagnosis (or if newly registered in the preceding 12 months a record of an FEV1/FVC ratio below 0.7 recorded within 6 months of registration); and 3) Patients with a clinical diagnosis of COPD on or after 1 April who are unable to undertake spirometry. (Based on NM169) |
8 | N/A |
| COPD003 The percentage of patients with COPD who have had a review, undertaken by a healthcare professional, including an assessment of breathlessness using the Medical Research Council dyspnoea scale in the preceding 12 months (NM104) | COPD010 The percentage of patients with COPD on the register, who have had a review in the preceding 12 months, including a record of the number of exacerbations and an assessment of breathlessness using the Medical Research Council dyspnoea scale (NM170). | 9 | 50-90% |
| 2019/20 indicator wording | Agreed new wording in 2020/21 | Points | Payment thresholds |
| HF002 The percentage of patients with a diagnosis of heart failure (diagnosed on or after 1 April 2006) which has been confirmed by an echocardiogram or by specialist assessment 3 months before or 12 months after entering on to the register (NM116) | HF005 The percentage of patients with a diagnosis of heart failure after 1 April 2020 which has been confirmed by: 1) an echocardiogram or by specialist assessment between 3 months before or 6 months after entering on to the register; or 2) if newly registered in the preceding 12 months, with a record of an echocardiogram or a specialist assessment within 6 months of the date of registration. (Based on NM71) |
6 | 50-90% |
| HF003 In those patients with a current diagnosis of heart failure due to left ventricular systolic function, the percentage of patients who are currently treated with an ACE-I or ARB (NM89) | HF003 The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with an ACE-I or ARB (NM172) | 6 | 60-92% |
| HF004 In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally treated with a beta-blocker licensed for heart failure (NM90) | HF006 The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure (NM173) | 6 | 60-92% |
| N/A | HF007 The percentage of patients with heart failure on the register, who had a review in the preceding 12 months, including an assessment of function capacity and a review of medication to ensure medicines optimisation at maximum tolerated doses. (Based on NM174). | 7 | 50-90% |
| Agreed indicator wording | Points | Payment thresholds |
The percentage of patients with non-diabetic hyperglycaemia who have had an HbA1c or FPG test in the preceding 12 months | 18 | 50-90% |
Or, please register for a free trial to access all of the guides and unlock all features.
© Cogora 2024
